“Personalized Medicine Driving Esoteric Testing Growth”
- Personalized medicine is transforming esoteric testing by enabling diagnostics tailored to individual genetic and molecular profiles, enhancing treatment precision and patient outcomes
- For instance, oncology tests now detect specific gene mutations to recommend targeted therapies for cancer patients
- Technologies such as next-generation sequencing and mass spectrometry are pivotal in identifying unique biomarkers, facilitating early detection and targeted therapies
- For instance, sequencing-based tests can detect inherited conditions such as Lynch syndrome, allowing for proactive treatment planning
- Companies such as Quest Diagnostics have introduced consumer-initiated genetic tests, empowering individuals to assess their health risks and make informed decisions
- Collaborations between diagnostic firms and pharmaceutical companies are fostering the development of companion diagnostics, aligning treatments with specific patient needs
- The integration of artificial intelligence in esoteric testing is streamlining data analysis, improving diagnostic accuracy, and supporting the advancement of personalized healthcare
